PathGroup Expands Operations with Proscia Concentriq Dx

PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, is expanding its operations with Proscia’s Concentriq® Dx* to further enhance the delivery of faster, higher quality results for millions of patients, helping to better inform treatment decisions.

*Concentriq Dx is CE-marked under IVDR and is available for primary diagnosis in the US during the COVID-19 public health emergency.